Does GOLIMUMAB Cause Hypercholesterolaemia? 1,271 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,271 reports of Hypercholesterolaemia have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 1.8% of all adverse event reports for GOLIMUMAB.
1,271
Reports of Hypercholesterolaemia with GOLIMUMAB
1.8%
of all GOLIMUMAB reports
1,114
Deaths
820
Hospitalizations
How Dangerous Is Hypercholesterolaemia From GOLIMUMAB?
Of the 1,271 reports, 1,114 (87.6%) resulted in death, 820 (64.5%) required hospitalization, and 884 (69.6%) were considered life-threatening.
Is Hypercholesterolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 1,271 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Hypercholesterolaemia?
ALENDRONATE (1,607)
METHOTREXATE (1,547)
TOCILIZUMAB (1,483)
ADALIMUMAB (1,479)
ABATACEPT (1,410)
RITUXIMAB (1,389)
PREDNISONE (1,377)
INFLIXIMAB (1,338)
DICLOFENAC (1,331)
LEFLUNOMIDE (1,322)
Which GOLIMUMAB Alternatives Have Lower Hypercholesterolaemia Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN